Review



mef cells  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    ATCC mef cells
    Catalytically active MTMR7 is essential for STIM1/ORAI1 activity (A) Schematic representation of the MTMR7 protein domains. The PH-GRAM domain is shown in yellow, the catalytic protein tyrosine phosphatase (PTP) domain in green, and the coiled-coil (CC) domain in pink. The location of the STIM1 binding region at the C-terminus of MTMR7 is indicated in the figure. The location of the stop codon introduced at the N-terminal amino acid residues of the STIM1 interaction site (S569∗) is indicated by a red X, the location of C338S and D343A mutations in the catalytic PTP domain is indicated by blue arrows. (B) Immunoblot analysis of wild-type and MTMR7 mutants expressed <t>in</t> <t>HEK293T</t> cells. Anti-GAPDH was used as a loading control. (C and D) Co-immunoprecipitation of MTMR7 and STIM1 in HEK293T cells co-transfected with STIM1-YFP and either MTMR7, MTMR-C338S, or MTMR-D343A mutants. Immunoprecipitation was performed using GFP-Trap agarose beads, followed by immunoblotting with anti MTMR7 ( C ) and anti STIM1 ( D ) antibodies. (E) Representative whole-cell current traces of heterologously expressed ORAI1 and STIM1, along with MTRM7 or MTMR7 mutants MTMR7-C338S, MTMR7-D343A, and MTMR7-S569∗ in MTMR7 −/− cells. Cells were transfected in a 1:2:1 (ORAI1:STIM1:MTMR7 or MTMR7 mutants) ratio. Currents were recorded in 20 mM Ca 2+ during 200 ms hyperpolarizing test voltages (−60, −80, −100, and −120 mV) from a 30-mV holding potential. (F) Current density (pA/pF) analysis of current from a −100-mV hyperpolarizing pulse at 3 min following whole-cell break-in (white bars; n = 6–13 for each group). Green bar denotes the current density measured from a −100-mV pulse at 15 min following whole-cell break-in ( n = 3). A nonparametric Kruskal-Wallis ANOVA on ranks test, followed by a multiple comparison (Dunn’s) post hoc test, was used to compare each group against either the control ( Ctrl ) condition in wild-type or MTMR7 −/− <t>MEF</t> cells (∗ p < 0.001 vs. wild-type, # p < 0.01 vs. MTMR7 −/− ). (G) Extent of STIM1/ORAI1 CDI from recordings of each group shown in F. Line and scatterplot summarizing the fraction of current remaining for each group, measured as the percent of peak current from the beginning and the end of the 200 ms hyperpolarizing steps. Each data point represents the mean ± SEM ( n = 6–15 cells for each group). For comparison, the data from wild-type or MTMR7 −/− cells were superimposed from D in gray and black dashed lines, respectively. A one-way ANOVA followed by a Dunnett’s post hoc test was used to compare the residual current of all groups against the control (WT) (∗ p < 0.05 at all test potentials). Data are represented as mean ± SEM.
    Mef Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 558 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mef cells/product/ATCC
    Average 95 stars, based on 558 article reviews
    mef cells - by Bioz Stars, 2026-06
    95/100 stars

    Images

    1) Product Images from "Localized phosphoinositide metabolism regulates STIM1/ORAI1 fast inactivation"

    Article Title: Localized phosphoinositide metabolism regulates STIM1/ORAI1 fast inactivation

    Journal: iScience

    doi: 10.1016/j.isci.2026.115543

    Catalytically active MTMR7 is essential for STIM1/ORAI1 activity (A) Schematic representation of the MTMR7 protein domains. The PH-GRAM domain is shown in yellow, the catalytic protein tyrosine phosphatase (PTP) domain in green, and the coiled-coil (CC) domain in pink. The location of the STIM1 binding region at the C-terminus of MTMR7 is indicated in the figure. The location of the stop codon introduced at the N-terminal amino acid residues of the STIM1 interaction site (S569∗) is indicated by a red X, the location of C338S and D343A mutations in the catalytic PTP domain is indicated by blue arrows. (B) Immunoblot analysis of wild-type and MTMR7 mutants expressed in HEK293T cells. Anti-GAPDH was used as a loading control. (C and D) Co-immunoprecipitation of MTMR7 and STIM1 in HEK293T cells co-transfected with STIM1-YFP and either MTMR7, MTMR-C338S, or MTMR-D343A mutants. Immunoprecipitation was performed using GFP-Trap agarose beads, followed by immunoblotting with anti MTMR7 ( C ) and anti STIM1 ( D ) antibodies. (E) Representative whole-cell current traces of heterologously expressed ORAI1 and STIM1, along with MTRM7 or MTMR7 mutants MTMR7-C338S, MTMR7-D343A, and MTMR7-S569∗ in MTMR7 −/− cells. Cells were transfected in a 1:2:1 (ORAI1:STIM1:MTMR7 or MTMR7 mutants) ratio. Currents were recorded in 20 mM Ca 2+ during 200 ms hyperpolarizing test voltages (−60, −80, −100, and −120 mV) from a 30-mV holding potential. (F) Current density (pA/pF) analysis of current from a −100-mV hyperpolarizing pulse at 3 min following whole-cell break-in (white bars; n = 6–13 for each group). Green bar denotes the current density measured from a −100-mV pulse at 15 min following whole-cell break-in ( n = 3). A nonparametric Kruskal-Wallis ANOVA on ranks test, followed by a multiple comparison (Dunn’s) post hoc test, was used to compare each group against either the control ( Ctrl ) condition in wild-type or MTMR7 −/− MEF cells (∗ p < 0.001 vs. wild-type, # p < 0.01 vs. MTMR7 −/− ). (G) Extent of STIM1/ORAI1 CDI from recordings of each group shown in F. Line and scatterplot summarizing the fraction of current remaining for each group, measured as the percent of peak current from the beginning and the end of the 200 ms hyperpolarizing steps. Each data point represents the mean ± SEM ( n = 6–15 cells for each group). For comparison, the data from wild-type or MTMR7 −/− cells were superimposed from D in gray and black dashed lines, respectively. A one-way ANOVA followed by a Dunnett’s post hoc test was used to compare the residual current of all groups against the control (WT) (∗ p < 0.05 at all test potentials). Data are represented as mean ± SEM.
    Figure Legend Snippet: Catalytically active MTMR7 is essential for STIM1/ORAI1 activity (A) Schematic representation of the MTMR7 protein domains. The PH-GRAM domain is shown in yellow, the catalytic protein tyrosine phosphatase (PTP) domain in green, and the coiled-coil (CC) domain in pink. The location of the STIM1 binding region at the C-terminus of MTMR7 is indicated in the figure. The location of the stop codon introduced at the N-terminal amino acid residues of the STIM1 interaction site (S569∗) is indicated by a red X, the location of C338S and D343A mutations in the catalytic PTP domain is indicated by blue arrows. (B) Immunoblot analysis of wild-type and MTMR7 mutants expressed in HEK293T cells. Anti-GAPDH was used as a loading control. (C and D) Co-immunoprecipitation of MTMR7 and STIM1 in HEK293T cells co-transfected with STIM1-YFP and either MTMR7, MTMR-C338S, or MTMR-D343A mutants. Immunoprecipitation was performed using GFP-Trap agarose beads, followed by immunoblotting with anti MTMR7 ( C ) and anti STIM1 ( D ) antibodies. (E) Representative whole-cell current traces of heterologously expressed ORAI1 and STIM1, along with MTRM7 or MTMR7 mutants MTMR7-C338S, MTMR7-D343A, and MTMR7-S569∗ in MTMR7 −/− cells. Cells were transfected in a 1:2:1 (ORAI1:STIM1:MTMR7 or MTMR7 mutants) ratio. Currents were recorded in 20 mM Ca 2+ during 200 ms hyperpolarizing test voltages (−60, −80, −100, and −120 mV) from a 30-mV holding potential. (F) Current density (pA/pF) analysis of current from a −100-mV hyperpolarizing pulse at 3 min following whole-cell break-in (white bars; n = 6–13 for each group). Green bar denotes the current density measured from a −100-mV pulse at 15 min following whole-cell break-in ( n = 3). A nonparametric Kruskal-Wallis ANOVA on ranks test, followed by a multiple comparison (Dunn’s) post hoc test, was used to compare each group against either the control ( Ctrl ) condition in wild-type or MTMR7 −/− MEF cells (∗ p < 0.001 vs. wild-type, # p < 0.01 vs. MTMR7 −/− ). (G) Extent of STIM1/ORAI1 CDI from recordings of each group shown in F. Line and scatterplot summarizing the fraction of current remaining for each group, measured as the percent of peak current from the beginning and the end of the 200 ms hyperpolarizing steps. Each data point represents the mean ± SEM ( n = 6–15 cells for each group). For comparison, the data from wild-type or MTMR7 −/− cells were superimposed from D in gray and black dashed lines, respectively. A one-way ANOVA followed by a Dunnett’s post hoc test was used to compare the residual current of all groups against the control (WT) (∗ p < 0.05 at all test potentials). Data are represented as mean ± SEM.

    Techniques Used: Activity Assay, Binding Assay, Western Blot, Control, Immunoprecipitation, Transfection, Comparison

    MTMR7 double mutants and ORAI1 inactivation (A) Immunoblot analysis of HEK293T cells expressing MTMR7 and MTMR7 mutants (MTMR7-C338S, MTMR7-D343A, MTMR7-C338S + S569∗, and MTMR7-D343A + S569∗). (B) Representative whole-cell current traces of heterologously expressed ORAI1 and STIM1, along with MTMR7 double mutants; MTMR7-C338S + S569∗ or MTMR7-D343A + S569∗ in MTMR7 −/− cells. Cells were transfected in a 1:2:1 (ORAI1:STIM1:MTMR7 double mutants) ratio. Currents were recorded in 20 mM Ca 2+ during 200 ms hyperpolarizing test voltages (−60, −80, −100, −120 mV) from a 30-mV holding potential. (C) Current density (pA/pF) analysis of current from a −100-mV hyperpolarizing pulse at 3 min following whole-cell break-in (white bars; n = 7 for each group). (D) Extent of STIM1/ORAI1 CDI from recordings of each group shown in F. Line and scatterplot summarizing the fraction of current remaining for each group, measured as the percent of peak current from the beginning and the end of the 200 ms hyperpolarizing steps. Each data point represents the mean ± SEM (n = 8–9 cells for each group). For comparison, the data from wild-type MEF or MTMR7 −/− cells were superimposed from D in gray and black dashed lines, respectively. A one-way ANOVA followed by a Dunnett’s post hoc test was used to compare the residual current of all groups against the control (WT) (∗ p < 0.05 at all test potentials). Data are represented as mean ± SEM.
    Figure Legend Snippet: MTMR7 double mutants and ORAI1 inactivation (A) Immunoblot analysis of HEK293T cells expressing MTMR7 and MTMR7 mutants (MTMR7-C338S, MTMR7-D343A, MTMR7-C338S + S569∗, and MTMR7-D343A + S569∗). (B) Representative whole-cell current traces of heterologously expressed ORAI1 and STIM1, along with MTMR7 double mutants; MTMR7-C338S + S569∗ or MTMR7-D343A + S569∗ in MTMR7 −/− cells. Cells were transfected in a 1:2:1 (ORAI1:STIM1:MTMR7 double mutants) ratio. Currents were recorded in 20 mM Ca 2+ during 200 ms hyperpolarizing test voltages (−60, −80, −100, −120 mV) from a 30-mV holding potential. (C) Current density (pA/pF) analysis of current from a −100-mV hyperpolarizing pulse at 3 min following whole-cell break-in (white bars; n = 7 for each group). (D) Extent of STIM1/ORAI1 CDI from recordings of each group shown in F. Line and scatterplot summarizing the fraction of current remaining for each group, measured as the percent of peak current from the beginning and the end of the 200 ms hyperpolarizing steps. Each data point represents the mean ± SEM (n = 8–9 cells for each group). For comparison, the data from wild-type MEF or MTMR7 −/− cells were superimposed from D in gray and black dashed lines, respectively. A one-way ANOVA followed by a Dunnett’s post hoc test was used to compare the residual current of all groups against the control (WT) (∗ p < 0.05 at all test potentials). Data are represented as mean ± SEM.

    Techniques Used: Western Blot, Expressing, Transfection, Comparison, Control



    Similar Products

    95
    ATCC mef cells
    Catalytically active MTMR7 is essential for STIM1/ORAI1 activity (A) Schematic representation of the MTMR7 protein domains. The PH-GRAM domain is shown in yellow, the catalytic protein tyrosine phosphatase (PTP) domain in green, and the coiled-coil (CC) domain in pink. The location of the STIM1 binding region at the C-terminus of MTMR7 is indicated in the figure. The location of the stop codon introduced at the N-terminal amino acid residues of the STIM1 interaction site (S569∗) is indicated by a red X, the location of C338S and D343A mutations in the catalytic PTP domain is indicated by blue arrows. (B) Immunoblot analysis of wild-type and MTMR7 mutants expressed <t>in</t> <t>HEK293T</t> cells. Anti-GAPDH was used as a loading control. (C and D) Co-immunoprecipitation of MTMR7 and STIM1 in HEK293T cells co-transfected with STIM1-YFP and either MTMR7, MTMR-C338S, or MTMR-D343A mutants. Immunoprecipitation was performed using GFP-Trap agarose beads, followed by immunoblotting with anti MTMR7 ( C ) and anti STIM1 ( D ) antibodies. (E) Representative whole-cell current traces of heterologously expressed ORAI1 and STIM1, along with MTRM7 or MTMR7 mutants MTMR7-C338S, MTMR7-D343A, and MTMR7-S569∗ in MTMR7 −/− cells. Cells were transfected in a 1:2:1 (ORAI1:STIM1:MTMR7 or MTMR7 mutants) ratio. Currents were recorded in 20 mM Ca 2+ during 200 ms hyperpolarizing test voltages (−60, −80, −100, and −120 mV) from a 30-mV holding potential. (F) Current density (pA/pF) analysis of current from a −100-mV hyperpolarizing pulse at 3 min following whole-cell break-in (white bars; n = 6–13 for each group). Green bar denotes the current density measured from a −100-mV pulse at 15 min following whole-cell break-in ( n = 3). A nonparametric Kruskal-Wallis ANOVA on ranks test, followed by a multiple comparison (Dunn’s) post hoc test, was used to compare each group against either the control ( Ctrl ) condition in wild-type or MTMR7 −/− <t>MEF</t> cells (∗ p < 0.001 vs. wild-type, # p < 0.01 vs. MTMR7 −/− ). (G) Extent of STIM1/ORAI1 CDI from recordings of each group shown in F. Line and scatterplot summarizing the fraction of current remaining for each group, measured as the percent of peak current from the beginning and the end of the 200 ms hyperpolarizing steps. Each data point represents the mean ± SEM ( n = 6–15 cells for each group). For comparison, the data from wild-type or MTMR7 −/− cells were superimposed from D in gray and black dashed lines, respectively. A one-way ANOVA followed by a Dunnett’s post hoc test was used to compare the residual current of all groups against the control (WT) (∗ p < 0.05 at all test potentials). Data are represented as mean ± SEM.
    Mef Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mef cells/product/ATCC
    Average 95 stars, based on 1 article reviews
    mef cells - by Bioz Stars, 2026-06
    95/100 stars
      Buy from Supplier

    95
    ATCC mouse embryonic fibroblast mef cell line
    Catalytically active MTMR7 is essential for STIM1/ORAI1 activity (A) Schematic representation of the MTMR7 protein domains. The PH-GRAM domain is shown in yellow, the catalytic protein tyrosine phosphatase (PTP) domain in green, and the coiled-coil (CC) domain in pink. The location of the STIM1 binding region at the C-terminus of MTMR7 is indicated in the figure. The location of the stop codon introduced at the N-terminal amino acid residues of the STIM1 interaction site (S569∗) is indicated by a red X, the location of C338S and D343A mutations in the catalytic PTP domain is indicated by blue arrows. (B) Immunoblot analysis of wild-type and MTMR7 mutants expressed <t>in</t> <t>HEK293T</t> cells. Anti-GAPDH was used as a loading control. (C and D) Co-immunoprecipitation of MTMR7 and STIM1 in HEK293T cells co-transfected with STIM1-YFP and either MTMR7, MTMR-C338S, or MTMR-D343A mutants. Immunoprecipitation was performed using GFP-Trap agarose beads, followed by immunoblotting with anti MTMR7 ( C ) and anti STIM1 ( D ) antibodies. (E) Representative whole-cell current traces of heterologously expressed ORAI1 and STIM1, along with MTRM7 or MTMR7 mutants MTMR7-C338S, MTMR7-D343A, and MTMR7-S569∗ in MTMR7 −/− cells. Cells were transfected in a 1:2:1 (ORAI1:STIM1:MTMR7 or MTMR7 mutants) ratio. Currents were recorded in 20 mM Ca 2+ during 200 ms hyperpolarizing test voltages (−60, −80, −100, and −120 mV) from a 30-mV holding potential. (F) Current density (pA/pF) analysis of current from a −100-mV hyperpolarizing pulse at 3 min following whole-cell break-in (white bars; n = 6–13 for each group). Green bar denotes the current density measured from a −100-mV pulse at 15 min following whole-cell break-in ( n = 3). A nonparametric Kruskal-Wallis ANOVA on ranks test, followed by a multiple comparison (Dunn’s) post hoc test, was used to compare each group against either the control ( Ctrl ) condition in wild-type or MTMR7 −/− <t>MEF</t> cells (∗ p < 0.001 vs. wild-type, # p < 0.01 vs. MTMR7 −/− ). (G) Extent of STIM1/ORAI1 CDI from recordings of each group shown in F. Line and scatterplot summarizing the fraction of current remaining for each group, measured as the percent of peak current from the beginning and the end of the 200 ms hyperpolarizing steps. Each data point represents the mean ± SEM ( n = 6–15 cells for each group). For comparison, the data from wild-type or MTMR7 −/− cells were superimposed from D in gray and black dashed lines, respectively. A one-way ANOVA followed by a Dunnett’s post hoc test was used to compare the residual current of all groups against the control (WT) (∗ p < 0.05 at all test potentials). Data are represented as mean ± SEM.
    Mouse Embryonic Fibroblast Mef Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse embryonic fibroblast mef cell line/product/ATCC
    Average 95 stars, based on 1 article reviews
    mouse embryonic fibroblast mef cell line - by Bioz Stars, 2026-06
    95/100 stars
      Buy from Supplier

    94
    Cyagen Biosciences mef cells
    Analysis of apoptosis and senescence <t>in</t> <t>ACE2-HEK293T</t> cells following SARS-CoV-2 infection. (A) Western blot analysis of caspase 3 cleavage in ACE2-HEK293T cells infected with SARS-CoV-2 (MOI = 0.1) for 24 hours. Caspase 3 activator raptinal (5 μM) was used as a positive control, with treatment for 6 hours. Viral infection was confirmed by Nucleocapsid (N) detection. The black asterisk indicates cleaved caspase 3. (B, C) Representative flow cytometry analysis (B) and statistical analysis (C) of apoptosis using Annexin V and PI staining in ACE2-HEK293T cells infected with SARS-CoV-2 (MOI = 0.1) at 0, 12, 24, and 48 hours post-infection. (D) The β-galactosidase activity of cells at 48 hours post-infection with SARS-CoV-2 (MOI = 0.1). Senescent cells are stained blue, as indicated by arrows. (E) The expression of senescence-associated genes CDKN1A , CDKN2A , IL1A , and IL8 in ACE2-HEK293T cells infected with SARS-CoV-2 (MOI = 0.1). (F) Western blot analysis of p21, p16, Lamin B1 and Nucleocapsid (N) expression in ACE2-HEK293T, ACE2-A549, Caco-2, and <t>ACE2-MEF</t> cells, either mock-treated or infected with SARS-CoV-2 at an MOI of 0.1 for 48 hours. (G) ELISA analysis of secreted IL-8 in cell culture supernatants of ACE2-A549 and Caco-2 cells at 48 hours after mock treatment or infection with SARS-CoV-2 (MOI = 0.1). Each experiment was independently repeated three times with similar results, and the representative images were shown. Mean ± SEM. ** P < 0.01; *** P < 0.001; **** P < 0.0001.
    Mef Cells, supplied by Cyagen Biosciences, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mef cells/product/Cyagen Biosciences
    Average 94 stars, based on 1 article reviews
    mef cells - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    95
    ATCC mouse embryonic fibroblast mef cells
    Analysis of apoptosis and senescence <t>in</t> <t>ACE2-HEK293T</t> cells following SARS-CoV-2 infection. (A) Western blot analysis of caspase 3 cleavage in ACE2-HEK293T cells infected with SARS-CoV-2 (MOI = 0.1) for 24 hours. Caspase 3 activator raptinal (5 μM) was used as a positive control, with treatment for 6 hours. Viral infection was confirmed by Nucleocapsid (N) detection. The black asterisk indicates cleaved caspase 3. (B, C) Representative flow cytometry analysis (B) and statistical analysis (C) of apoptosis using Annexin V and PI staining in ACE2-HEK293T cells infected with SARS-CoV-2 (MOI = 0.1) at 0, 12, 24, and 48 hours post-infection. (D) The β-galactosidase activity of cells at 48 hours post-infection with SARS-CoV-2 (MOI = 0.1). Senescent cells are stained blue, as indicated by arrows. (E) The expression of senescence-associated genes CDKN1A , CDKN2A , IL1A , and IL8 in ACE2-HEK293T cells infected with SARS-CoV-2 (MOI = 0.1). (F) Western blot analysis of p21, p16, Lamin B1 and Nucleocapsid (N) expression in ACE2-HEK293T, ACE2-A549, Caco-2, and <t>ACE2-MEF</t> cells, either mock-treated or infected with SARS-CoV-2 at an MOI of 0.1 for 48 hours. (G) ELISA analysis of secreted IL-8 in cell culture supernatants of ACE2-A549 and Caco-2 cells at 48 hours after mock treatment or infection with SARS-CoV-2 (MOI = 0.1). Each experiment was independently repeated three times with similar results, and the representative images were shown. Mean ± SEM. ** P < 0.01; *** P < 0.001; **** P < 0.0001.
    Mouse Embryonic Fibroblast Mef Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse embryonic fibroblast mef cells/product/ATCC
    Average 95 stars, based on 1 article reviews
    mouse embryonic fibroblast mef cells - by Bioz Stars, 2026-06
    95/100 stars
      Buy from Supplier

    96
    AMS Biotechnology mouse embryonic fibroblasts
    Analysis of apoptosis and senescence <t>in</t> <t>ACE2-HEK293T</t> cells following SARS-CoV-2 infection. (A) Western blot analysis of caspase 3 cleavage in ACE2-HEK293T cells infected with SARS-CoV-2 (MOI = 0.1) for 24 hours. Caspase 3 activator raptinal (5 μM) was used as a positive control, with treatment for 6 hours. Viral infection was confirmed by Nucleocapsid (N) detection. The black asterisk indicates cleaved caspase 3. (B, C) Representative flow cytometry analysis (B) and statistical analysis (C) of apoptosis using Annexin V and PI staining in ACE2-HEK293T cells infected with SARS-CoV-2 (MOI = 0.1) at 0, 12, 24, and 48 hours post-infection. (D) The β-galactosidase activity of cells at 48 hours post-infection with SARS-CoV-2 (MOI = 0.1). Senescent cells are stained blue, as indicated by arrows. (E) The expression of senescence-associated genes CDKN1A , CDKN2A , IL1A , and IL8 in ACE2-HEK293T cells infected with SARS-CoV-2 (MOI = 0.1). (F) Western blot analysis of p21, p16, Lamin B1 and Nucleocapsid (N) expression in ACE2-HEK293T, ACE2-A549, Caco-2, and <t>ACE2-MEF</t> cells, either mock-treated or infected with SARS-CoV-2 at an MOI of 0.1 for 48 hours. (G) ELISA analysis of secreted IL-8 in cell culture supernatants of ACE2-A549 and Caco-2 cells at 48 hours after mock treatment or infection with SARS-CoV-2 (MOI = 0.1). Each experiment was independently repeated three times with similar results, and the representative images were shown. Mean ± SEM. ** P < 0.01; *** P < 0.001; **** P < 0.0001.
    Mouse Embryonic Fibroblasts, supplied by AMS Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse embryonic fibroblasts/product/AMS Biotechnology
    Average 96 stars, based on 1 article reviews
    mouse embryonic fibroblasts - by Bioz Stars, 2026-06
    96/100 stars
      Buy from Supplier

    96
    Thermo Fisher cf 1 mitomycin c treated mef cells
    Analysis of apoptosis and senescence <t>in</t> <t>ACE2-HEK293T</t> cells following SARS-CoV-2 infection. (A) Western blot analysis of caspase 3 cleavage in ACE2-HEK293T cells infected with SARS-CoV-2 (MOI = 0.1) for 24 hours. Caspase 3 activator raptinal (5 μM) was used as a positive control, with treatment for 6 hours. Viral infection was confirmed by Nucleocapsid (N) detection. The black asterisk indicates cleaved caspase 3. (B, C) Representative flow cytometry analysis (B) and statistical analysis (C) of apoptosis using Annexin V and PI staining in ACE2-HEK293T cells infected with SARS-CoV-2 (MOI = 0.1) at 0, 12, 24, and 48 hours post-infection. (D) The β-galactosidase activity of cells at 48 hours post-infection with SARS-CoV-2 (MOI = 0.1). Senescent cells are stained blue, as indicated by arrows. (E) The expression of senescence-associated genes CDKN1A , CDKN2A , IL1A , and IL8 in ACE2-HEK293T cells infected with SARS-CoV-2 (MOI = 0.1). (F) Western blot analysis of p21, p16, Lamin B1 and Nucleocapsid (N) expression in ACE2-HEK293T, ACE2-A549, Caco-2, and <t>ACE2-MEF</t> cells, either mock-treated or infected with SARS-CoV-2 at an MOI of 0.1 for 48 hours. (G) ELISA analysis of secreted IL-8 in cell culture supernatants of ACE2-A549 and Caco-2 cells at 48 hours after mock treatment or infection with SARS-CoV-2 (MOI = 0.1). Each experiment was independently repeated three times with similar results, and the representative images were shown. Mean ± SEM. ** P < 0.01; *** P < 0.001; **** P < 0.0001.
    Cf 1 Mitomycin C Treated Mef Cells, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cf 1 mitomycin c treated mef cells/product/Thermo Fisher
    Average 96 stars, based on 1 article reviews
    cf 1 mitomycin c treated mef cells - by Bioz Stars, 2026-06
    96/100 stars
      Buy from Supplier

    Image Search Results


    Catalytically active MTMR7 is essential for STIM1/ORAI1 activity (A) Schematic representation of the MTMR7 protein domains. The PH-GRAM domain is shown in yellow, the catalytic protein tyrosine phosphatase (PTP) domain in green, and the coiled-coil (CC) domain in pink. The location of the STIM1 binding region at the C-terminus of MTMR7 is indicated in the figure. The location of the stop codon introduced at the N-terminal amino acid residues of the STIM1 interaction site (S569∗) is indicated by a red X, the location of C338S and D343A mutations in the catalytic PTP domain is indicated by blue arrows. (B) Immunoblot analysis of wild-type and MTMR7 mutants expressed in HEK293T cells. Anti-GAPDH was used as a loading control. (C and D) Co-immunoprecipitation of MTMR7 and STIM1 in HEK293T cells co-transfected with STIM1-YFP and either MTMR7, MTMR-C338S, or MTMR-D343A mutants. Immunoprecipitation was performed using GFP-Trap agarose beads, followed by immunoblotting with anti MTMR7 ( C ) and anti STIM1 ( D ) antibodies. (E) Representative whole-cell current traces of heterologously expressed ORAI1 and STIM1, along with MTRM7 or MTMR7 mutants MTMR7-C338S, MTMR7-D343A, and MTMR7-S569∗ in MTMR7 −/− cells. Cells were transfected in a 1:2:1 (ORAI1:STIM1:MTMR7 or MTMR7 mutants) ratio. Currents were recorded in 20 mM Ca 2+ during 200 ms hyperpolarizing test voltages (−60, −80, −100, and −120 mV) from a 30-mV holding potential. (F) Current density (pA/pF) analysis of current from a −100-mV hyperpolarizing pulse at 3 min following whole-cell break-in (white bars; n = 6–13 for each group). Green bar denotes the current density measured from a −100-mV pulse at 15 min following whole-cell break-in ( n = 3). A nonparametric Kruskal-Wallis ANOVA on ranks test, followed by a multiple comparison (Dunn’s) post hoc test, was used to compare each group against either the control ( Ctrl ) condition in wild-type or MTMR7 −/− MEF cells (∗ p < 0.001 vs. wild-type, # p < 0.01 vs. MTMR7 −/− ). (G) Extent of STIM1/ORAI1 CDI from recordings of each group shown in F. Line and scatterplot summarizing the fraction of current remaining for each group, measured as the percent of peak current from the beginning and the end of the 200 ms hyperpolarizing steps. Each data point represents the mean ± SEM ( n = 6–15 cells for each group). For comparison, the data from wild-type or MTMR7 −/− cells were superimposed from D in gray and black dashed lines, respectively. A one-way ANOVA followed by a Dunnett’s post hoc test was used to compare the residual current of all groups against the control (WT) (∗ p < 0.05 at all test potentials). Data are represented as mean ± SEM.

    Journal: iScience

    Article Title: Localized phosphoinositide metabolism regulates STIM1/ORAI1 fast inactivation

    doi: 10.1016/j.isci.2026.115543

    Figure Lengend Snippet: Catalytically active MTMR7 is essential for STIM1/ORAI1 activity (A) Schematic representation of the MTMR7 protein domains. The PH-GRAM domain is shown in yellow, the catalytic protein tyrosine phosphatase (PTP) domain in green, and the coiled-coil (CC) domain in pink. The location of the STIM1 binding region at the C-terminus of MTMR7 is indicated in the figure. The location of the stop codon introduced at the N-terminal amino acid residues of the STIM1 interaction site (S569∗) is indicated by a red X, the location of C338S and D343A mutations in the catalytic PTP domain is indicated by blue arrows. (B) Immunoblot analysis of wild-type and MTMR7 mutants expressed in HEK293T cells. Anti-GAPDH was used as a loading control. (C and D) Co-immunoprecipitation of MTMR7 and STIM1 in HEK293T cells co-transfected with STIM1-YFP and either MTMR7, MTMR-C338S, or MTMR-D343A mutants. Immunoprecipitation was performed using GFP-Trap agarose beads, followed by immunoblotting with anti MTMR7 ( C ) and anti STIM1 ( D ) antibodies. (E) Representative whole-cell current traces of heterologously expressed ORAI1 and STIM1, along with MTRM7 or MTMR7 mutants MTMR7-C338S, MTMR7-D343A, and MTMR7-S569∗ in MTMR7 −/− cells. Cells were transfected in a 1:2:1 (ORAI1:STIM1:MTMR7 or MTMR7 mutants) ratio. Currents were recorded in 20 mM Ca 2+ during 200 ms hyperpolarizing test voltages (−60, −80, −100, and −120 mV) from a 30-mV holding potential. (F) Current density (pA/pF) analysis of current from a −100-mV hyperpolarizing pulse at 3 min following whole-cell break-in (white bars; n = 6–13 for each group). Green bar denotes the current density measured from a −100-mV pulse at 15 min following whole-cell break-in ( n = 3). A nonparametric Kruskal-Wallis ANOVA on ranks test, followed by a multiple comparison (Dunn’s) post hoc test, was used to compare each group against either the control ( Ctrl ) condition in wild-type or MTMR7 −/− MEF cells (∗ p < 0.001 vs. wild-type, # p < 0.01 vs. MTMR7 −/− ). (G) Extent of STIM1/ORAI1 CDI from recordings of each group shown in F. Line and scatterplot summarizing the fraction of current remaining for each group, measured as the percent of peak current from the beginning and the end of the 200 ms hyperpolarizing steps. Each data point represents the mean ± SEM ( n = 6–15 cells for each group). For comparison, the data from wild-type or MTMR7 −/− cells were superimposed from D in gray and black dashed lines, respectively. A one-way ANOVA followed by a Dunnett’s post hoc test was used to compare the residual current of all groups against the control (WT) (∗ p < 0.05 at all test potentials). Data are represented as mean ± SEM.

    Article Snippet: Both MEF cells and human embryonic kidney cells (HEK293T; female, ATCC Cat# MSPP-CRL3216) were cultured in accordance with established protocols using DMEM-10 (Dulbecco’s Modified Eagle’s Medium supplemented with 10% Fetal Bovine Serum, Gibco) under standard cell culture conditions of 37°C and 5% CO 2 .

    Techniques: Activity Assay, Binding Assay, Western Blot, Control, Immunoprecipitation, Transfection, Comparison

    MTMR7 double mutants and ORAI1 inactivation (A) Immunoblot analysis of HEK293T cells expressing MTMR7 and MTMR7 mutants (MTMR7-C338S, MTMR7-D343A, MTMR7-C338S + S569∗, and MTMR7-D343A + S569∗). (B) Representative whole-cell current traces of heterologously expressed ORAI1 and STIM1, along with MTMR7 double mutants; MTMR7-C338S + S569∗ or MTMR7-D343A + S569∗ in MTMR7 −/− cells. Cells were transfected in a 1:2:1 (ORAI1:STIM1:MTMR7 double mutants) ratio. Currents were recorded in 20 mM Ca 2+ during 200 ms hyperpolarizing test voltages (−60, −80, −100, −120 mV) from a 30-mV holding potential. (C) Current density (pA/pF) analysis of current from a −100-mV hyperpolarizing pulse at 3 min following whole-cell break-in (white bars; n = 7 for each group). (D) Extent of STIM1/ORAI1 CDI from recordings of each group shown in F. Line and scatterplot summarizing the fraction of current remaining for each group, measured as the percent of peak current from the beginning and the end of the 200 ms hyperpolarizing steps. Each data point represents the mean ± SEM (n = 8–9 cells for each group). For comparison, the data from wild-type MEF or MTMR7 −/− cells were superimposed from D in gray and black dashed lines, respectively. A one-way ANOVA followed by a Dunnett’s post hoc test was used to compare the residual current of all groups against the control (WT) (∗ p < 0.05 at all test potentials). Data are represented as mean ± SEM.

    Journal: iScience

    Article Title: Localized phosphoinositide metabolism regulates STIM1/ORAI1 fast inactivation

    doi: 10.1016/j.isci.2026.115543

    Figure Lengend Snippet: MTMR7 double mutants and ORAI1 inactivation (A) Immunoblot analysis of HEK293T cells expressing MTMR7 and MTMR7 mutants (MTMR7-C338S, MTMR7-D343A, MTMR7-C338S + S569∗, and MTMR7-D343A + S569∗). (B) Representative whole-cell current traces of heterologously expressed ORAI1 and STIM1, along with MTMR7 double mutants; MTMR7-C338S + S569∗ or MTMR7-D343A + S569∗ in MTMR7 −/− cells. Cells were transfected in a 1:2:1 (ORAI1:STIM1:MTMR7 double mutants) ratio. Currents were recorded in 20 mM Ca 2+ during 200 ms hyperpolarizing test voltages (−60, −80, −100, −120 mV) from a 30-mV holding potential. (C) Current density (pA/pF) analysis of current from a −100-mV hyperpolarizing pulse at 3 min following whole-cell break-in (white bars; n = 7 for each group). (D) Extent of STIM1/ORAI1 CDI from recordings of each group shown in F. Line and scatterplot summarizing the fraction of current remaining for each group, measured as the percent of peak current from the beginning and the end of the 200 ms hyperpolarizing steps. Each data point represents the mean ± SEM (n = 8–9 cells for each group). For comparison, the data from wild-type MEF or MTMR7 −/− cells were superimposed from D in gray and black dashed lines, respectively. A one-way ANOVA followed by a Dunnett’s post hoc test was used to compare the residual current of all groups against the control (WT) (∗ p < 0.05 at all test potentials). Data are represented as mean ± SEM.

    Article Snippet: Both MEF cells and human embryonic kidney cells (HEK293T; female, ATCC Cat# MSPP-CRL3216) were cultured in accordance with established protocols using DMEM-10 (Dulbecco’s Modified Eagle’s Medium supplemented with 10% Fetal Bovine Serum, Gibco) under standard cell culture conditions of 37°C and 5% CO 2 .

    Techniques: Western Blot, Expressing, Transfection, Comparison, Control

    Analysis of apoptosis and senescence in ACE2-HEK293T cells following SARS-CoV-2 infection. (A) Western blot analysis of caspase 3 cleavage in ACE2-HEK293T cells infected with SARS-CoV-2 (MOI = 0.1) for 24 hours. Caspase 3 activator raptinal (5 μM) was used as a positive control, with treatment for 6 hours. Viral infection was confirmed by Nucleocapsid (N) detection. The black asterisk indicates cleaved caspase 3. (B, C) Representative flow cytometry analysis (B) and statistical analysis (C) of apoptosis using Annexin V and PI staining in ACE2-HEK293T cells infected with SARS-CoV-2 (MOI = 0.1) at 0, 12, 24, and 48 hours post-infection. (D) The β-galactosidase activity of cells at 48 hours post-infection with SARS-CoV-2 (MOI = 0.1). Senescent cells are stained blue, as indicated by arrows. (E) The expression of senescence-associated genes CDKN1A , CDKN2A , IL1A , and IL8 in ACE2-HEK293T cells infected with SARS-CoV-2 (MOI = 0.1). (F) Western blot analysis of p21, p16, Lamin B1 and Nucleocapsid (N) expression in ACE2-HEK293T, ACE2-A549, Caco-2, and ACE2-MEF cells, either mock-treated or infected with SARS-CoV-2 at an MOI of 0.1 for 48 hours. (G) ELISA analysis of secreted IL-8 in cell culture supernatants of ACE2-A549 and Caco-2 cells at 48 hours after mock treatment or infection with SARS-CoV-2 (MOI = 0.1). Each experiment was independently repeated three times with similar results, and the representative images were shown. Mean ± SEM. ** P < 0.01; *** P < 0.001; **** P < 0.0001.

    Journal: Frontiers in Immunology

    Article Title: Cellular sensor DAP5 decodes Betacoronaviral NSP5 to drive virus-induced senescence

    doi: 10.3389/fimmu.2026.1768183

    Figure Lengend Snippet: Analysis of apoptosis and senescence in ACE2-HEK293T cells following SARS-CoV-2 infection. (A) Western blot analysis of caspase 3 cleavage in ACE2-HEK293T cells infected with SARS-CoV-2 (MOI = 0.1) for 24 hours. Caspase 3 activator raptinal (5 μM) was used as a positive control, with treatment for 6 hours. Viral infection was confirmed by Nucleocapsid (N) detection. The black asterisk indicates cleaved caspase 3. (B, C) Representative flow cytometry analysis (B) and statistical analysis (C) of apoptosis using Annexin V and PI staining in ACE2-HEK293T cells infected with SARS-CoV-2 (MOI = 0.1) at 0, 12, 24, and 48 hours post-infection. (D) The β-galactosidase activity of cells at 48 hours post-infection with SARS-CoV-2 (MOI = 0.1). Senescent cells are stained blue, as indicated by arrows. (E) The expression of senescence-associated genes CDKN1A , CDKN2A , IL1A , and IL8 in ACE2-HEK293T cells infected with SARS-CoV-2 (MOI = 0.1). (F) Western blot analysis of p21, p16, Lamin B1 and Nucleocapsid (N) expression in ACE2-HEK293T, ACE2-A549, Caco-2, and ACE2-MEF cells, either mock-treated or infected with SARS-CoV-2 at an MOI of 0.1 for 48 hours. (G) ELISA analysis of secreted IL-8 in cell culture supernatants of ACE2-A549 and Caco-2 cells at 48 hours after mock treatment or infection with SARS-CoV-2 (MOI = 0.1). Each experiment was independently repeated three times with similar results, and the representative images were shown. Mean ± SEM. ** P < 0.01; *** P < 0.001; **** P < 0.0001.

    Article Snippet: The hACE2 transgenic C57BL/6 mice were purchased from Cyagen and used to extract MEF cells (ACE2-MEF in the article).

    Techniques: Infection, Western Blot, Positive Control, Flow Cytometry, Staining, Activity Assay, Expressing, Enzyme-linked Immunosorbent Assay, Cell Culture